Anti-Cytokine Therapy for Hemodialysis InflammatION
Condition: End-Stage Renal Disease Interventions: Drug: Anakinra; Drug: Placebo Sponsors: University of Pennsylvania; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting - verified May 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cytokine Therapy | Diabetes | Dialysis | Endocrinology | Hemodialysis | Urology & Nephrology